Would you consider using a JAK inhibitor for a patient with RA associated scleritis?
Patient previously trialed two anti-TNFi and Tocilizumab. Avoiding Rituximab due to positive JC virus testing.
2 Answers
Mednet Member
Rheumatology · UPMC Regional Orthopedics
Answered on
Yes, I have used it before with success when with limited options. I recommend speaking to the MSL from one of the JAKi developers and they can provide the data to make an informed decision or to appeal to insurance if denied.
Join for free or sign in to see the full answer
Mednet MemberInvited Expert
Rheumatology · Stony Brook University Hospital
Answered on
Absolutely, especially when the patient failed TNF and actemra, has contraindication to rituxan. Just not sure what +test here for JC virus.
Join for free or sign in to see the full answer